ANKRD34C activators represent a spectrum of chemical compounds that influence various biochemical pathways, ultimately enhancing the functional activity of ANKRD34C. Phorbol 12-myristate 13-acetate (PMA), through the activation of protein kinase C (PKC), and forskolin, by increasing cAMP levels and activating PKA, both contribute to the phosphorylation of proteins that may interact with ANKRD34C, leading to its enhanced activity. Ionomycin and A23187 (Calcimycin), as calcium ionophores, raise intracellular calcium levels which are critical for the activation of calcium-dependent signaling pathways that might affect ANKRD34C. Similarly, isoproterenol, through beta-adrenergic receptor stimulation, increases cAMP and activates PKA, which could have downstream effects on ANKRD34C activity. Retinoic acid, by modulating gene expression, can induce changes in the protein interaction network of ANKRD34C, while Epigallocatechin gallate (EGCG) and LY294002, by affecting kinase and phosphatase pathways and PI3K/AKT signaling respectively, might also enhance ANKRD34C's functional role.
The role of cyclic AMP is further underscored by the inclusion of dibutyryl-cAMP (db-cAMP), 8-Bromo-cAMP, and rolipram, a PDE4 inhibitor, all of which elevate intracellular cAMP levels and activate PKA, possibly influencing ANKRD34C activity by modifying the phosphorylation state of associated proteins.Sphingosine-1-phosphate (S1P), a lipid signaling molecule, activates its receptors leading to a cascade of downstream signaling events that could modulate the functional capacity of ANKRD34C. Through these diverse yet interconnected mechanisms, ANKRD34C activators collectively enhance the protein's activity without necessarily altering its expression levels, ensuring that ANKRD34C exerts its effects within the specific cellular context it operates. These compounds, by affecting distinct signaling pathways like PKC activation, cAMP-PKA axis modulation, calcium signaling, and kinase-phosphatase network interactions, orchestrate a concerted upregulation of ANKRD34C activity, thereby exemplifying the intricate nature of cellular signaling and the nuanced role of chemical activators in manipulating protein function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA functions as a diacylglycerol analog to activate protein kinase C (PKC), which can phosphorylate various substrates including proteins that interact with ANKRD34C, potentially enhancing its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which in turn activate PKA. PKA phosphorylation can lead to changes in protein-protein interactions involving ANKRD34C, thereby enhancing its functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent signaling pathways interacting with ANKRD34C, leading to its enhanced activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through retinoic acid receptors which can lead to changes in the expression of proteins that interact with or modify ANKRD34C function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can modulate various signaling pathways including those involving kinases and phosphatases which might alter the phosphorylation state of ANKRD34C, enhancing its activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA, potentially affecting the phosphorylation and function of ANKRD34C-associated proteins. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates S1P receptors, leading to downstream signaling that can modulate the activity of proteins functionally connected to ANKRD34C. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that elevates intracellular cAMP, leading to PKA activation that may enhance ANKRD34C activity through downstream signaling effects. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore, similar to Ionomycin, which increases intracellular calcium and could stimulate calcium-related pathways affecting ANKRD34C activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA, potentially influencing the phosphorylation state and activity of ANKRD34C. | ||||||